Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 219Rectal Neoplasms 137Stomach Neoplasms 95Colonic Neoplasms 87Pancreatic Neoplasms 82Esophageal Neoplasms 71Neoplasm Metastasis 58Squamous Cell Carcinoma of Head and Neck 43Head and Neck Neoplasms 42Adenocarcinoma Of Esophagus 37Neoplasms 36Breast Neoplasms 35Esophageal Squamous Cell Carcinoma 27Carcinoma, Hepatocellular 22Cholangiocarcinoma 21Adenocarcinoma 17Nasopharyngeal Carcinoma 16Bile Duct Neoplasms 14Gallbladder Neoplasms 13Carcinoma, Squamous Cell 13Biliary Tract Neoplasms 13Anus Neoplasms 13Urinary Bladder Neoplasms 11Liver Neoplasms 10Carcinoma 9Nasopharyngeal Neoplasms 8Colorectal Cancer Metastatic 8Peritoneal Neoplasms 7Recurrence 6Ovarian Neoplasms 6

Interventions

Oxaliplatin 3Radiotherapy 2Folfox protocol 2Fluorouracil 2Capecitabine 2Bevacizumab 2Artesunate 2camrelizumab 1apatinib 1alectinib 1XELOX 1Trastuzumab 1Ocoxin 1Leucovorin 1Irinotecan 1Drug Therapy 1Chemoradiotherapy 1ABT-165 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Intestinal Neoplasms × Fluorouracil × Clear all
NCT03368859 2021-02-09

A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab

AbbVie

Phase 2 Terminated
70 enrolled 12 charts
Gastrointestinal

Intestinal Neoplasms, Neoplasms, Colorectal Neoplasms

NCT02241499 2020-02-28

PALAESTRA

Lund University Hospital

Phase 2 Completed
29 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡